Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis - Quiz - MDSpire

Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis

  • By

  • Ahmed B Bayoumy

  • Lindsay M Clarke

  • Parakkal Deepak

  • Aakash Desai

  • Priya Sehgal

  • uri Gorelik

  • Haggai Bar-Yoseph

  • Marie Villumsen

  • Chris J J Mulder

  • Dirk J Stenvers

  • Maarten E Tushuizen

  • Nanne K H de Boer

  • October 10, 2025

  • 0 min

Share

Original Source(s)

Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis

  • by Ahmed B Bayoumy, Lindsay M Clarke, Parakkal Deepak, Aakash Desai, Priya Sehgal, uri Gorelik, Haggai Bar-Yoseph, Marie Villumsen, Chris J J Mulder, Dirk J Stenvers, Maarten E Tushuizen, Nanne K H de Boer

  • October 10, 2025

Related Content

Retraction Note: Intrathoracic Migration of Gastric Sleeve Affects Weight Loss as well as GERD–an Analysis of Remnant Gastric Morphology for 100 Patients at One Year After Laparoscopic Sleeve Gastrectomy

The innovation trap: How pharma weaponizes a word to extend monopolies

Probiotic Effect on Quality of Life, Bowel Habits and Weight Loss after Different Types of Bariatric Surgeries, a Randomized Controlled Trial